<VariationArchive VariationID="844532" VariationName="NM_002863.5(PYGL):c.911_914dup (p.Leu305fs)" VariationType="Duplication" Accession="VCV000844532" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="841550" VariationID="844532">
      <GeneList>
        <Gene Symbol="PYGL" FullName="glycogen phosphorylase L" GeneID="5836" HGNC_ID="HGNC:9725" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="50905217" stop="50944483" display_start="50905217" display_stop="50944483" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="51371934" stop="51411247" display_start="51371934" display_stop="51411247" Strand="-" />
          </Location>
          <OMIM>613741</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002863.5(PYGL):c.911_914dup (p.Leu305fs)</Name>
      <CanonicalSPDI>NC_000014.9:50917046:AAGG:AAGGAAGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="50917046" stop="50917047" display_start="50917046" display_stop="50917047" variantLength="4" positionVCF="50917046" referenceAlleleVCF="C" alternateAlleleVCF="CAAGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="51383764" stop="51383765" display_start="51383764" display_stop="51383765" variantLength="4" positionVCF="51383764" referenceAlleleVCF="C" alternateAlleleVCF="CAAGG" />
      </Location>
      <ProteinChange>L305fs</ProteinChange>
      <ProteinChange>L271fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002863.4" sequenceAccession="NM_002863" sequenceVersion="4" change="c.911_914dupCCTT">
            <Expression>NM_002863.4:c.911_914dupCCTT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.51383765_51383768dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.51383765_51383768dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.50917047_50917050dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.50917047_50917050dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012796.1" sequenceAccession="NG_012796" sequenceVersion="1" change="g.32481_32484dup">
            <Expression>NG_012796.1:g.32481_32484dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001163940.2" sequenceAccession="NM_001163940" sequenceVersion="2" change="c.809_812dup">
            <Expression>NM_001163940.2:c.809_812dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157412.1" sequenceAccession="NP_001157412" sequenceVersion="1" change="p.Leu271fs">
            <Expression>NP_001157412.1:p.Leu271fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002863.5" sequenceAccession="NM_002863" sequenceVersion="5" change="c.911_914dup" MANESelect="true">
            <Expression>NM_002863.5:c.911_914dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002854.3" sequenceAccession="NP_002854" sequenceVersion="3" change="p.Leu305fs">
            <Expression>NP_002854.3:p.Leu305fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="758943884" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002863.5(PYGL):c.911_914dup (p.Leu305fs) AND Glycogen storage disease, type VI" Accession="RCV001047405" Version="6">
        <ClassifiedConditionList TraitSetID="3244">
          <ClassifiedCondition DB="MedGen" ID="C0017925">Glycogen storage disease, type VI</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-05" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21646031</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32505569</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536091</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3244" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10922" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 6</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hers disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphorylase deficiency glycogen-storage disease of liver</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type VI</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+6/3126" DB="Genetic Alliance" />
                <XRef ID="29291001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic glycogen phosphorylase deficiency</ElementValue>
                <XRef ID="237971004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD VI</ElementValue>
                <XRef Type="MIM" ID="232700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD6</ElementValue>
                <XRef Type="MIM" ID="232700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzyme catalyzes the rate-limiting step in glycogen degradation, and deficiency of the enzyme in the untreated child is characterized by hepatomegaly, poor growth, ketotic hypoglycemia, elevated hepatic transaminases, hyperlipidemia, and low prealbumin level. GSD VI is usually a relatively mild disorder that presents in infancy and childhood; rare cases of more severe disease manifesting with recurrent hypoglycemia and marked hepatomegaly have been described. More common complications in the setting of suboptimal metabolic control include short stature, delayed puberty, osteopenia, and osteoporosis. Hepatic fibrosis commonly develops in GSD VI, but cirrhosis and hypertrophic cardiomyopathy are rare. Clinical and biochemical abnormalities may decrease with age, but ketosis and hypoglycemia can continue to occur.</Attribute>
                <XRef ID="NBK5941" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6529" />
                <XRef ID="6529" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301760</ID>
                <ID Source="BookShelf">NBK5941</ID>
              </Citation>
              <XRef ID="369" DB="Orphanet" />
              <XRef ID="C0017925" DB="MedGen" />
              <XRef ID="MONDO:0009294" DB="MONDO" />
              <XRef Type="MIM" ID="232700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2376688" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="5796408|MedGen:C0017925" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001211362" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9536091</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21646031</ID>
          </Citation>
          <Comment>Loss-of-function variants in PYGL are known to be pathogenic (PMID: 9536091, 21646031). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with PYGL-related conditions. This variant is present in population databases (rs758943884, ExAC 0.004%). This sequence change creates a premature translational stop signal (p.Leu305Phefs*25) in the PYGL gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.51383764_51383765insAAGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017925" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7522889" SubmissionDate="2023-07-25" DateLastUpdated="2023-07-29" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_002863.4:c.911_914dupCCTT|MedGen:C0017925" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004020902" DateUpdated="2023-07-29" DateCreated="2023-07-29" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32505569</ID>
          </Citation>
          <Comment>Variant summary: PYGL c.911_914dupCCTT (p.Leu305PhefsX25) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.2e-05 in 251486 control chromosomes (gnomAD v2.1). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.911_914dupCCTT has been reported in the literature in at least one compound heterozygous individual affected with Glycogen storage disease, type VI (e.g., Degrassi_2021). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication was ascertained in the context of this evaluation (PMID: 32505569). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002863.4:c.911_914dupCCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017925" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13707883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2376688" TraitType="Disease" MappingType="XRef" MappingValue="C0017925" MappingRef="MedGen">
        <MedGen CUI="C0017925" Name="Glycogen storage disease, type VI" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7522889" TraitType="Disease" MappingType="XRef" MappingValue="C0017925" MappingRef="MedGen">
        <MedGen CUI="C0017925" Name="Glycogen storage disease, type VI" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

